Literature DB >> 10772931

Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes.

J W Mockridge1, M S Marber, R J Heads.   

Abstract

In the present study we have investigated whether Akt was activated during simulated ischemia (SI) and simulated ischemia/reperfusion (SI/R) in neonatal rat cardiomyocytes. Akt was phosphorylated on both S473 and T308 residues after 10 min of simulated SI/R and remained elevated for 60 min before returning to basal levels after 2 h. No phosphorylation was observed during SI alone. SI/R-stimulated Akt activation was inhibited by the phosphatidylinositol 3-kinase (PI3-K) inhibitor wortmannin, the tyrosine kinase inhibitor genistein and the Src tyrosine kinase inhibitor PP2, indicating a requirement for tyrosine kinase activity in Akt activation. Furthermore, SB203580, a p38 MAPK inhibitor, partially inhibited Akt activation. SI/R also induced the phosphorylation of PHAS-I, a downstream Akt target, in a wortmannin-dependent manner. These results demonstrate for the first time that SI/R stimulates Akt activation via PI3-K-and Src tyrosine kinase-dependent pathways, whereas p38 MAPK appears to be involved in maintaining Akt activation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772931     DOI: 10.1006/bbrc.2000.2522

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Inhibition of fast sodium current in rabbit ventricular myocytes by protein tyrosine kinase inhibitors.

Authors:  Yanggan Wang; Mary B Wagner; Rajiv Kumar; Jun Cheng; Ronald W Joyner
Journal:  Pflugers Arch       Date:  2003-04-26       Impact factor: 3.657

2.  PI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System.

Authors:  Kujaany Kana; Hannah Song; Carol Laschinger; Peter W Zandstra; Milica Radisic
Journal:  Tissue Eng Part A       Date:  2015-08-07       Impact factor: 3.845

3.  PLCδ1 protein rescues ischemia-reperfused heart by the regulation of calcium homeostasis.

Authors:  Soyeon Lim; Woochul Chang; Min-Ji Cha; Byeong-Wook Song; Onju Ham; Se-Yeon Lee; Changyoun Lee; Jun-Hee Park; Sang-Kyou Lee; Yangsoo Jang; Ki-Chul Hwang
Journal:  Mol Ther       Date:  2014-03-18       Impact factor: 11.454

4.  Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Authors:  Tána Ravingerová; Jana Matejíková; Jan Neckár; Eva Andelová; Frantisek Kolár
Journal:  Mol Cell Biochem       Date:  2006-10-03       Impact factor: 3.396

5.  Ischemia/reperfusion reduces transcription factor Sp1-mediated cystathionine beta-synthase expression in the kidney.

Authors:  Nan Wu; Yaw L Siow; Karmin O
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

6.  Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.

Authors:  A Punn; J W Mockridge; S Farooqui; M S Marber; R J Heads
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

7.  Injury-triggered Akt phosphorylation of Cx43: a ZO-1-driven molecular switch that regulates gap junction size.

Authors:  Clarence A Dunn; Paul D Lampe
Journal:  J Cell Sci       Date:  2013-11-08       Impact factor: 5.285

8.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

9.  Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.

Authors:  Rui-Qu Zhang; Dong-Ye Li; Tong-da Xu; Sha-Sha Zhu; Huan-Jun Pan; Fang Fang; Xin Wu; Hong Sun
Journal:  Chin J Integr Med       Date:  2016-03-08       Impact factor: 1.978

10.  Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.

Authors:  Krisztina Kovacs; Ambrus Toth; Peter Deres; Tamas Kalai; Kalman Hideg; Balazs Sumegi
Journal:  Exp Clin Cardiol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.